Arie Belldegrun - Sep 16, 2021 Form 3/A - Amendment Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Director
Signature
/s/ Karen Tepichin, Attorney-in-fact
Stock symbol
DNA
Transactions as of
Sep 16, 2021
Transactions value $
$0
Form type
3/A - Amendment
Date filed
3/28/2022, 05:30 PM
Date Of Original Report
Sep 20, 2021
Previous filing
Jun 23, 2021
Next filing
Jan 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DNA Class A Common Stock 18.7K Sep 16, 2021 Direct
holding DNA Class A Common Stock 500K Sep 16, 2021 By Bellco Legacy LLC F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DNA Warrants Sep 16, 2021 Class A Common Stock 3.75K $11.50 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares of Class A Common Stock acquired in a pro rata distribution in-kind, the acquisition of which was exempt pursuant to Rule 16a-9.
F2 Bellco Legacy LLC is owned and managed by trusts controlled by the reporting person and Rebecka Belldegrun.